Increasing researches reported that CDH1, BRCA2, and BRCA1 were susceptibility genes for BC (Petridis et al., 2019) and around 60–70% of women with BRCA1 or BRCA2 gene mutations would be suffered with BC in her lifetime (Antoniou et al., 2003). This evidence concerns the gene BRCA2 and breast cancer.